Literature DB >> 23306813

Using extracorporeal membrane oxygenation to rescue acute myocardial infarction with cardiopulmonary collapse: the impact of early coronary revascularization.

Meng-Yu Wu1, Yuan-His Tseng, Yu-Sheng Chang, Feng-Chun Tsai, Pyng-Jing Lin.   

Abstract

OBJECTIVES: To investigate the therapeutic impact of combining extracorporeal membrane oxygenation (ECMO) and early coronary revascularization on acute myocardial infarction (AMI)-induced cardiopulmonary collapse.
MATERIALS AND METHODS: This retrospective study included 35 consecutive patients rescued by ECMO for AMI-induced cardiopulmonary collapse in a single institution between June 2003 and December 2011. Coronary revascularization was performed soon after ECMO initiation. Percutaneous coronary intervention (PCI) was the primary revascularization strategy. Coronary artery bypass grafting (CABG) was performed if an unsuitable anatomy or unsatisfactory result of PCI. Comparisons were performed in groups with different revascularization strategies and outcomes.
RESULTS: Among the 35 patients, 16 underwent CABG and 1 was bridged to transplant after CABG. Compared to patients receiving PCI only, the CABG group showed similar results in ECMO weaning (58% vs. 69%, p=0.51), hospital discharge (32% vs. 50%, p=0.27), and left ventricular ejection fraction before discharge (45% vs. 49%, p=0.92). Regardless of revascularization strategies, this protocol achieved an ECMO-weaning rate of 63% and a hospital discharge rate of 40%. Dialysis-dependent acute renal failure (OR 5.4, 95% CI: 1.1-27.5) and profound anoxic encephalopathy (OR 5.4, 95% CI: 1.1-27.5) predicted non-weaning of ECMO. Age>60 years (OR 7.3, 95% CI: 1.1-51.0) and profound anoxic encephalopathy (OR 24.6, 95% CI: 2.3-263.0) predicted in-hospital mortality. The major cardiovascular adverse effect (MACE)-free survival was 77% in the first year after discharge.
CONCLUSION: Early revascularization on ECMO is practical to preserve myocardial viability and bridge patients collapsing with AMI to recovery.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23306813     DOI: 10.1016/j.resuscitation.2012.12.019

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  12 in total

1.  [Use of ECMO in adult patients with cardiogenic shock: a position paper of the Austrian Society of Cardiology].

Authors:  Philipp Pichler; Herwig Antretter; Martin Dünser; Stephan Eschertzhuber; Roman Gottardi; Gottfried Heinz; Gerhard Pölzl; Ingrid Pretsch; Angelika Rajek; Andrä Wasler; Daniel Zimpfer; Alexander Geppert
Journal:  Wien Klin Wochenschr       Date:  2015-03-28       Impact factor: 1.704

2.  Could Selective Re-look Angiography Improve the Outcome of Cardiogenic Shock in Patients Under Veno-arterial Extracorporeal Membrane Oxygenator?

Authors:  Maurice Maksoud; Amr S Omar; Praveen Sivadasan; Tamer Abdalghafoor; Alaa Rahhal; Tasnim Abdalla; Bassam Shoman; Rula Taha; Abdulaziz AlKhulaifi
Journal:  J Cardiovasc Transl Res       Date:  2022-01-24       Impact factor: 3.216

3.  The feasibility of venovenous extracorporeal life support to treat acute respiratory failure in adult cancer patients.

Authors:  Meng-Yu Wu; Tzu-I Wu; Yuan-His Tseng; Wen-Chi Shen; Yu-Sheng Chang; Chung-Chi Huang; Pyng-Jing Lin
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

4.  Clinical outcomes of patients with acute myocardial infarction complicated by severe refractory cardiogenic shock assisted with percutaneous cardiopulmonary support.

Authors:  Taek Kyu Park; Jeong Hoon Yang; Seung-Hyuk Choi; Young Bin Song; Joo-Yong Hahn; Jin-Ho Choi; Kiick Sung; Young Tak Lee; Hyeon-Cheol Gwon; Sang Hoon Lee
Journal:  Yonsei Med J       Date:  2014-07       Impact factor: 2.759

Review 5.  Overview of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support for the Management of Cardiogenic Shock.

Authors:  Adamantios Tsangaris; Tamas Alexy; Rajat Kalra; Marinos Kosmopoulos; Andrea Elliott; Jason A Bartos; Demetris Yannopoulos
Journal:  Front Cardiovasc Med       Date:  2021-07-07

6.  The pre-ECMO simplified acute physiology score II as a predictor for mortality in patients with initiation ECMO support at the emergency department for acute circulatory and/or respiratory failure: a retrospective study.

Authors:  Kun Il Kim; Hee Sung Lee; Hyoung Soo Kim; Sang Ook Ha; Won Yong Lee; Sang Jun Park; Sun Hee Lee; Tae Hun Lee; Jeong Yeol Seo; Hyun Hee Choi; Kyu Tae Park; Sang Jin Han; Kyung Soon Hong; Sung Mi Hwang; Jae Jun Lee
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2015-08-17       Impact factor: 2.953

7.  Use of Extracorporeal Membrane Oxygenation to Rescue Patients With Refractory Ventricular Arrhythmia in Acute Myocardial Infarction.

Authors:  Chih-Fan Yeh; Chih-Hsien Wang; Pi-Ru Tsai; Cho-Kai Wu; Yen-Hung Lin; Yih-Sharng Chen
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

8.  In-hospital mortality and successful weaning from venoarterial extracorporeal membrane oxygenation: analysis of 5,263 patients using a national inpatient database in Japan.

Authors:  Shotaro Aso; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Crit Care       Date:  2016-04-05       Impact factor: 9.097

9.  Role of epinephrine and extracorporeal membrane oxygenation in the management of ischemic refractory ventricular fibrillation: a randomized trial in pigs.

Authors:  Jason A Bartos; Sebastian Voicu; Timothy R Matsuura; Adamantios Tsangaris; Georgios Sideris; Brett A Oestreich; Stephen A George; Matthew Olson; Kadambari Chandra Shekar; Jennifer N Rees; Kathleen Carlson; Pierre Sebastian; Scott McKnite; Ganesh Raveendran; Tom P Aufderheide; Demetris Yannopoulos
Journal:  JACC Basic Transl Sci       Date:  2017-06-21

10.  Relationship between Clinical Outcomes and Cardiopulmonary Resuscitation Time in Patients with Acute Myocardial Infarction Treated by Extracorporeal Membrane Oxygenation-Assisted Primary Percutaneous Coronary Intervention.

Authors:  Sungsoo Cho; Wonkyung Lee; Seong Hoon Lim; Tae Soo Kang
Journal:  Korean Circ J       Date:  2018-08       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.